We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

JRVR:NASDAQJames River Group Holdings, Inc. Analysis

Data as of 2026-04-12 - not real-time

$6.20

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

James River Group (JRVR) trades at a trailing P/E of 7.5, well below the industry average of 17.1, indicating a significant valuation discount. The price‑to‑book ratio of 0.53 and a DCF‑derived upside of ~24% further support an undervalued assessment. Revenue has surged 32% year‑over‑year, driven by strong growth in its excess and surplus lines business. The combined ratio improved to 96.6% from 117.6% a year earlier, signaling better underwriting profitability. Net income rebounded to $47.4 million, reversing a prior loss and delivering a 15% return on tangible equity. The dividend yield of 0.65% is backed by a 4.8% payout ratio, suggesting the dividend is sustainable.
Technically, the stock sits at $6.20, below both the 20‑day (6.26) and 50‑day (6.55) moving averages, indicating short‑term pressure. However, the RSI of 45 and a bullish MACD histogram hint at a potential bottom‑fade. Volume trends are decreasing, and 30‑day volatility is high at 42%, contributing to a moderate liquidity risk. The beta of 0.54 points to lower market sensitivity, tempering overall risk. Given the valuation gap, improving fundamentals, and modest technical support at $5.92, the stock appears poised for a medium‑term rebound. Consequently, we recommend a buy stance for medium and long horizons, with a hold approach in the near term pending confirmation of price stability.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price near support
  • decreasing volume
  • high volatility

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • undervalued valuation
  • strong revenue growth
  • improved underwriting profitability

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • sustainable dividend
  • low payout ratio
  • stable cash generation

Key Metrics & Analysis

Financial Health

Revenue Growth32.40%
Profit Margin6.90%
P/E Ratio7.5
ROE7.88%
ROA0.94%
Debt/Equity50.19
P/B Ratio0.5
Op. Cash Flow$-18786000
Free Cash Flow$1.0B
Industry P/E17.1

Technical Analysis

TrendNeutral
RSI45.1
Support$5.92
Resistance$6.64
MA 20$6.26
MA 50$6.55
MA 200$5.97
MACDBullish
VolumeDecreasing
Fear & Greed Index87.09

Valuation

Fair Value$826.10
Target Price$7.67
Upside/Downside23.66%
GradeUndervalued
TypeBlend
Dividend Yield0.65%

Risk Assessment

Beta0.54
Volatility42.18%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.